⌘K
Loading ticker…
Ecovyst Inc. · Healthcare · Chemicals
As of 2026-06-26, Ecovyst Inc. (ECVT) has a 3-month relative strength percentile of 30 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 55. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 2.8%, relative volume 4.00×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
30 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Related searches
ECVT is held by 6 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $46M notional. Top 3 carry $115M.
Top 6 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $46M |
| IWMiShares Russell 2000 ETF | 0.05% | $36M |
| VBVanguard Small Cap ETF | 0.02% | $33M |
| VBRVanguard Small Cap Value ETF | 0.03% | $21M |
| VXFVanguard Extended Market ETF | 0.02% | $16M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $2M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ECVT Jan avg: 5.95% median: 5.31% win: 75% σ: 10.14% n: 4 2022-04-12 → 2026-05-29 | ECVT Feb avg: -1.59% median: -0.04% win: 50% σ: 8.58% n: 4 2022-04-12 → 2026-05-29 | ECVT Mar avg: 7.76% median: 12.08% win: 75% σ: 11.21% n: 4 2022-04-12 → 2026-05-29 | ECVT Apr avg: -3.15% median: -3.55% win: 40% σ: 10.11% n: 5 2022-04-12 → 2026-05-29 | ECVT May avg: 1.35% median: -1.38% win: 40% σ: 13.99% n: 5 2022-04-12 → 2026-05-29 | ECVT Jun avg: 4.24% median: 3.46% win: 50% σ: 9.43% n: 4 2022-04-12 → 2026-05-29 (current) | ECVT Jul avg: 5.52% median: 5.49% win: 100% σ: 1.55% n: 4 2022-04-12 → 2026-05-29 | ECVT Aug avg: -11.38% median: -13.18% win: 25% σ: 12.87% n: 4 2022-04-12 → 2026-05-29 | ECVT Sep avg: -5.20% median: -4.25% win: 0% σ: 2.34% n: 4 2022-04-12 → 2026-05-29 | ECVT Oct avg: 0.53% median: -4.64% win: 25% σ: 11.71% n: 4 2022-04-12 → 2026-05-29 | ECVT Nov avg: 7.14% median: 7.90% win: 75% σ: 11.25% n: 4 2022-04-12 → 2026-05-29 | ECVT Dec avg: -0.03% median: -0.64% win: 50% σ: 5.06% n: 4 2022-04-12 → 2026-05-29 |